Public still 'hugely underestimating' how much more dangerous COVID-19 is for the elderly
Americans are still "hugely underestimating" just how much more dangerous COVID-19 is for the elderly, David Wallace-Wells writes for New York.
Data compiled throughout the course of the pandemic from various countries show that "all else being equal an unvaccinated 66-year-old is about 30 times more likely to die, given a confirmed case, than an unvaccinated 36-year-old." Even more drastically, an 85-year-old faces a fatality risk of more than 10,000 times the one faced by a 10-year-old children, Wallace-Wells writes.
He suggests that the age skew may be even more important to emphasize now in the wake of mass vaccinations. While the vaccines have "utterly transformed the shape of pandemic" and remain safe and effective — both in terms of preventing transmission and especially reducing the risk of severe disease — the vaccinated elderly still have a greater chance of dying from an infection than younger people, regardless of their vaccination status. British data, for instance, suggest a vaccinated 80-year-old has about the same mortality risk as an unvaccinated 50-year-old. And when there are breakthrough infections, the most severe cases overwhelmingly belong to older age groups.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"Encouraging further vaccination remains by far the best tool we have in fighting the pandemic to an endgame détente," Wallace-Wells writes, but he adds that "we should also be clear along the way about the continuing risks to the vaccinated elderly and what might be done to protect them." Read the full piece at New York.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
The Week Unwrapped: Why are sinkholes becoming more common?
Podcast Plus, will Saudi investment help create the "Netflix of sport"? And why has New Zealand's new tourism campaign met with a savage reception?
By The Week UK Published
-
How Poland became Europe's military power
The Explainer Warsaw has made its armed forces a priority as it looks to protect its borders and stay close to the US
By Elizabeth Carr-Ellis, The Week UK Published
-
Quiz of The Week: 15 - 21 February
Have you been paying attention to The Week's news?
By The Week Staff Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
How close are we to a norovirus vaccine?
Today's Big Question A new Moderna trial raises hopes of vanquishing a stomach bug that sickens millions a year
By David Faris Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published